Biotechnology Synthesis, Evaluating Benefit, Risk and Biodiversity
Target Malaria's 2019 Burkina Faso release involved genetically modified sterile male mosquitoes in a preliminary study, not gene-drive mosquitoes. Proposed gene drives aim to bias inheritance and could suppress malaria-vector populations, but spread depends on drive design, fitness, resistance and ecology. IQ2 closes by applying a full evaluation framework to the proposed technology without confusing a preliminary release with gene-drive deployment.
Connect evidence to synthesis
Retrieve the evidence needed for a balanced biotechnology judgement.
Three quick questions from earlier lessons. Pulling old material back to mind before you learn something new makes the new material stick better, so this is not busywork.
Practise this lesson
Four printable worksheets that build from the foundations up to exam-style questions, start at whatever level suits you.
Framework for evaluating biotechnology applications, benefit, risk, stakeholders, biodiversity, qualified conclusion.
You are asked: To what extent do genetic techniques benefit society? A weak answer would list a few benefits and stop there.
Write what else a strong answer should include. Try to name at least three categories of judgement beyond simple benefit-listing.
Know
- Strong biotechnology judgements include benefit, risk, biodiversity and stakeholder dimensions.
- Different case studies can point in different directions.
- Absolute answers are usually weaker than conditional ones.
Understand
- Biotechnology can be beneficial overall in one context and problematic in another.
- Good synthesis compares, weighs and qualifies.
- Case-study evidence matters more than generic opinion language.
Apply
- Build balanced extended responses.
- Use multiple case studies in one answer.
- Answer "affect biodiversity" rather than drifting into "improve production" only.
Core Content
Explain the evaluation framework
Use claim, evidence, mechanism, limitation and judgement.
Judgement structure · five moves in order
A proposed gene drive for malaria-vector suppression is a useful evaluation case. Its intended benefit is public health, while biodiversity and ecosystem effects are potential consequences to investigate. Gene drives bias inheritance, but spread is not automatically 100% or universally irreversible: resistance, fitness, design and population structure matter. The 2019 Burkina Faso sterile-male release was a preliminary study rather than gene-drive deployment. A strong evaluation distinguishes demonstrated evidence from a future proposal and includes affected communities.
1. State the benefit
Identify the biological or social problem the technology may help solve.
2. State the risk or limitation
Identify welfare, environmental, ownership, access or uncertainty issues.
3. Identify stakeholders
Explain who benefits, who carries risk and whether the distribution is fair.
4. Include biodiversity
Explain whether genetic, species or ecosystem diversity is supported or reduced.
5. Conclude conditionally
Judge to what extent the benefit outweighs the risk, and under what conditions.
A complete biotechnology evaluation uses five moves: identify the benefit, describe the risk or limitation, analyse stakeholder impact, assess the biodiversity effect at a named level, and reach a conditional conclusion, the strongest answers are conditional, not one-sided.
Pause, copy the highlighted framework into your book before moving on.
Which feature is most important in a strong synthesis answer about biotechnology?
Represent contrasting cases
Compare benefits and risks across applications.
Case comparison · medicine vs agriculture vs animals
We just saw that a five-move framework structures strong evaluations. That raises a question: how do those moves play out differently across medical, agricultural and animal cases? This card answers it → case-specific evaluation dimensions.
Medical biotechnology case
- Can offer major health benefits, such as better diagnosis or biological medicine production.
- Main evaluation issues: access, cost, safety, consent and fairness.
Agricultural biotechnology case
- Can improve yield, resistance or efficiency.
- Main evaluation issues: ownership, monoculture risk, farmer dependence and biodiversity trade-offs.
Animal biotechnology case
- Can support production or medical research.
- Main evaluation issues: welfare, necessity, harm and ethical justification.
Because the balance differs across cases, synthesis answers should compare cases rather than forcing one universal conclusion too early.
Medical biotechnology raises access, cost, safety and consent issues; agricultural biotechnology raises ownership, monoculture and biodiversity trade-offs; animal biotechnology raises welfare, necessity and harm issues, compare cases rather than forcing one universal conclusion.
Add the highlighted point to your notes before the check below.
Why is comparing multiple case studies useful in biotechnology evaluation?
Respond at biodiversity scales
Move beyond productivity to genetic, species and ecosystem effects.
Keep the question on track · answer what is asked
We just saw that different case studies raise different evaluation issues. That raises a question: what does a poorly-written evaluation miss compared to a strong one? This card answers it → what to include and what to avoid.
Many weak responses drift into "this crop gives better yield" and stop there. That may be true, but the biodiversity question asks something more specific. Students must explain whether diversity at genetic, species or ecosystem level is preserved, reduced or changed in mixed ways.
Weak response
- "Biotechnology is good because it increases production."
- No biodiversity level identified.
- No risk, stakeholder or trade-off analysis.
Strong response
- Identifies benefit and biodiversity level.
- Explains whether diversity is supported or reduced.
- Includes conditions, risks and stakeholder impact.
A strong evaluation explicitly names the biodiversity level affected, states whether diversity is preserved or reduced, and adds conditions, risks and stakeholder impact, "biotechnology is good because it increases production" is a poor answer because it confuses productivity with biodiversity.
Pause, write the highlighted distinction into your book.
"This crop gives a better yield" fully answers a question about the biodiversity effect of a biotechnology.
Evaluating biotechnology requires balancing potential benefits against risks to human health, the environment, and biodiversity.
The risks of biotechnology can be fully predicted before any field trials are conducted.
Build a synthesis judgement
Make the conclusion qualified, comparative and evidence-led.
Conclusion skill · how to land the answer
We just saw that good evaluation names the biodiversity level and conditions. That raises a question: how should a final evaluative conclusion be written? This card answers it → conditional judgement language.
Good synthesis does not end with "there are pros and cons". It ends with a reasoned judgement. That judgement should be comparative and conditional. For example:
Stronger style
- "To a large extent, biotechnology benefits society in medicine, provided access and safety are well managed."
- "In agriculture, benefits may be substantial, but biodiversity trade-offs can reduce the overall value if diversity is narrowed too far."
This lesson is the final preparation for the checkpoint. Students should now be able to integrate the entire biotechnology inquiry question into one coherent answer.
Strong evaluative conclusions are comparative and conditional, use phrases such as "to a large extent", "provided that" and "in this context" to reach a qualified judgement rather than ending with "there are pros and cons" without a final position.
Pause, copy the highlighted language pattern into your notes before continuing.
A conclusion using conditional language such as "to a large extent" or "provided that" is called a _____ judgement.
Activities
Apply the synthesis
Organise evidence and construct a module-level response.
Build the Paragraph
Pick one biotechnology case and write four sentences using this order:
- Main benefit.
- Main risk or trade-off.
- Biodiversity or stakeholder impact.
- Final qualified judgement.
Compare Two Cases
Compare a medical biotechnology case with an agricultural biotechnology case. Explain why the balance of benefit and risk is not identical in both cases.
Core biological claim
- Biotechnology should be evaluated through benefit, risk, biodiversity effect and stakeholder impact together.
Mechanism or process
- A strong synthesis response compares case studies, weighs trade-offs and ends with a qualified judgement.
Common exam error
- Listing benefits only, or discussing productivity without answering the biodiversity part of the question.
Evaluative sentence starter
- "To a large extent, the biotechnology is beneficial in this context, but its overall value depends on stakeholder impact, biodiversity trade-offs and whether the benefits are distributed fairly."
Practise the lesson
Answer fresh questions, explain your reasoning and compare model responses.
A fresh set drawn from this lesson's question bank, feedback shown immediately. +5 XP per correct · +25 XP all correct
Pick your answer, then rate your confidence, that tells the system what to drill next.
UnderstandBand 3(3 marks) 1. Outline a framework for evaluating biotechnology.
AnalyseBand 4(4 marks) 2. Explain why a strong answer about biotechnology should compare more than one case study.
EvaluateBand 5–6(5 marks) 3. Evaluate the statement: Biotechnology benefits society, so the main task is just to maximise its use.
Show all answers
Multiple choice
MC answers and full explanations are shown inline as you complete each question. Use the retry button to attempt a fresh set from the lesson bank.
Activity 1, Build the paragraph
A strong paragraph should state the biotechnology benefit, identify a trade-off or limitation, explain biodiversity or stakeholder impact, and then end with a qualified judgement such as "to a large extent" or "provided that".
Activity 2, Compare two cases
A good comparison would explain that medical biotechnology may offer strong direct health benefits but raise issues of cost and access, while agricultural biotechnology may improve productivity but raise ownership and biodiversity trade-offs. The key is that the balance is not identical across cases.
Short Answer Model Responses
Q1 (3 marks): A strong framework for evaluating biotechnology includes identifying the benefit [1], identifying risks or limitations [1], and judging stakeholder and biodiversity effects before reaching a qualified conclusion [1].
Q2 (4 marks): More than one case study is useful because different biotechnologies produce different balances of benefit and risk [1]. A medical case may emphasise health and access, while an agricultural case may emphasise productivity and biodiversity trade-offs [1]. Comparing cases makes evaluation more evidence-based and less one-sided [1]. Therefore multiple cases strengthen synthesis and lead to more accurate judgement [1].
Q3 (5 marks): The statement is incomplete because biotechnology may benefit society, but benefit alone does not justify maximising use without evaluation [1]. Biotechnology can improve medicine, productivity or conservation in some contexts [1]. However, it may also create trade-offs involving biodiversity, stakeholder fairness, ownership, welfare or access [1]. Therefore the key task is not simply maximisation, but careful evaluation of where and how biotechnology should be used [1]. Its value depends on whether benefits outweigh risks in the specific context [1].
Review and reflect
Retrieve the big ideas, test your fluency and revisit your opening claim.
Strong synthesis
Benefit + risk + biodiversity + stakeholder impact + qualified judgement.
Case comparison
Different biotechnologies produce different trade-offs.
Biodiversity focus
Do not drift into productivity-only answers.
Exam trap
Ending with "there are pros and cons" instead of a reasoned conclusion.
Rapid-fire questions synthesising benefit, risk, biodiversity and qualified judgement across IQ2. Beat the boss to bank a tier, gold (perfect + fast), silver (80%+), or bronze (cleared).
Return to the proposed gene-drive case. You should now be able to build a structured evaluation: identify the intended public-health benefit; distinguish the 2019 sterile-male study from future gene-drive deployment; investigate inheritance, resistance and ecological uncertainty; and include the participation of affected communities. A strong HSC response qualifies its judgement using evidence rather than assuming either perfect spread or inevitable failure.